Navigation Links
Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins. Conference call scheduled for 10 a.m. ET today.
Date:8/14/2014

>%

-140 bpsReported Operating Margin

8.3

%

11.5

%

-320 bpsAdjusted Operating Margin

13.9

%

16.4

%

-250 bpsThe Nutritionals segment reported fourth quarter net sales of $145 million as new product sales of $6 million were more than offset by $4 million in discontinued products and lower year-over-year sales in the infant/toddler food and VMS categories.

Fourth quarter gross margin was impacted by the timing of maintenance at the manufacturing facilities, while operating margin was impacted by increased promotional investments to support the launch of the branded probiotic insync®.

Rx PharmaceuticalsRx Pharmaceuticals Segment(in millions)(see the attached Table II for reconciliation to GAAP numbers)(YoY % Change may not calculate due to rounding)Fiscal 2014Fiscal 2013Fourth Quarter

EndedFourth Quarter

Ended


YoY

6/28/20146/29/2013% ChangeNet Sales

$253.4$194.7+30

%Reported Gross Profit

$135.6$92.3+47

%Adjusted Gross Profit

$153.1$109.0+40

%Reported Operating Income

$89.3

SOURCE Perrigo Company plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins
2. Perrigo Company plc Announces Quarterly Dividend
3. Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%
4. Perrigo Company plc To Host Investor Day And To Present At The 32nd Annual J.P. Morgan Healthcare Conference
5. Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals
6. Perrigo Confirms Filing For Generic Version Of Acanya
7. Perrigo Shareholders Approve Proposals Related To Perrigos Proposed Acquisition Of Elan
8. Perrigo Company Announces Tender Offer and Consent Solicitation for its 2.950% Notes due 2023
9. Perrigo Initiates Nationwide Voluntary Product Recall Of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due To A Potential Defect With The Co-Packaged Oral Syringe
10. Perrigo Reports Record First Quarter Revenue, Adjusted Earnings And Margins
11. Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... MOUNTAIN VIEW, Calif. , Oct. 20, 2014 /PRNewswire/ ... field of interventional pulmonology, today announced completion of enrollment ... schedule.  The RENEW Clinical Study is the FDA-approved IDE ... treatment for severe emphysema. It was anticipated ... US in February 2013, would take until the end ...
(Date:10/20/2014)... 20, 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Surgeons Annual Meeting that they have joined forces ... The collaboration is the first of its kind ... patient outcomes. NICO,s BrainPath® interventional access technology and ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... June 4 After three long years of ... of Phoebe Sumter Medical Center welcomed the arrival of a ... Siemens Healthcare. The new MRI scanner premiered today at the ... destroyed the hospital in 2007. State and local political dignitaries ...
... Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary ... and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... version of Pfizer,s Neurontin® Tablets for the treatment of postherpetic neuralgia, ... Pharmaceuticals Inc. , , ...
Cached Medicine Technology:Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 2Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 3Mylan Receives Approval for Generic Version of Neurontin® Tablets 2
(Date:10/22/2014)... For Dr. Iris Hunter, a job is more than just ... life’s mission. Her extensive experience in the nonprofit sector, coupled ... make it clear that Hunter’s mission is to serve others. ... a difference in the lives of others,” Hunter said. “Additionally, ... I felt ready to start on this journey as a ...
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the ... has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is ... around the world. , “iPower is one of the ... providing various kinds of useful products for new and ... excellent customer service and a number of features which ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2
... Even while their blood pressures are still normal, overweight ... known to increase pressures as well as early signs ... Georgia researchers looking at 126 healthy 15- to17-year-olds in ... highest among the overweight males. Early intervention could help ...
... form of childhood epilepsy called infantile spasms have developed ... closely resembling those occurring in patients with infantile seizures. ... scientists to test treatments that may benefit children. ... a seizure. Many of them go on to have ...
... Annuity offers a simplified solution to generating lifetime income ... , - Simple A share structure , , ... of a new retirement income product designed to bring the ... the reach of traditional variable annuities. The new product, John ...
... Products Earn Mention in New Stop Growing Older ... Grow ... his just released book "Stop Growing Older ... Grow Younger," ... the multi-billion-dollar anti-aging industry. Throughout the pages of this resource, ... advocating instead an all-natural approach to slowing down the aging ...
... 1 Abbott will present at the Goldman Sachs 30th ... D. White, chairman and chief executive officer, and Thomas C. ... make a presentation on the company at 9:20 a.m. Central ... presentation will be accessible through Abbott,s Investor Relations Web site ...
... standard chemotherapy, an international Phase III trial has shown ... for patients with advanced non-small cell lung cancer, according ... Anderson Cancer Center. The findings, presented today at ... the first clinical benefit of a small molecule targeted ...
Cached Medicine News:Health News:Overweight male teens with normal blood pressures showing signs of heart damage 2Health News:Overweight male teens with normal blood pressures showing signs of heart damage 3Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 2Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 3Health News:John Hancock Launches New Retirement Income Solution 2Health News:John Hancock Launches New Retirement Income Solution 3Health News:John Hancock Launches New Retirement Income Solution 4Health News:John Hancock Launches New Retirement Income Solution 5Health News:Explorer's Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: